почта: bd@sidmexinovia.com
Телефон: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Главная >
Imjudo 300mg Injection 15ml
Imjudo 300mg Injection 15ml
Manufacturer/Marketed By : ASTRAZENECA PHARMA INDIA LTD
$4737.35 $3884.64
Imjudo 300mg Injection 15ml is an advanced immunotherapy used in the treatment of certain types of cancer. It contains Tremelimumab, a type of monoclonal antibody that belongs to the pharmacological...
Сворачиваемый текст идеально подходит для длинных текстов, таких как абзацы и описания. Это отличный способ предоставить людям больше информации, сохраняя при этом лаконичность макета. Вы можете связать текст с чем угодно, включая внешний веб-сайт или другую страницу. Вы можете настроить текстовое поле так, чтобы оно разворачивалось и сворачивалось при щелчке пользователя, позволяя ему прочитать больше или меньше информации.
TREMELIMUMAB
Active Pharmaceutical Ingredient
Imjudo 300mg Injection 15ml
4 737,35 $
3 884,64 $
Imjudo 300mg Injection 15ml is an advanced immunotherapy used in the treatment of certain types of cancer. It contains Tremelimumab, a type of monoclonal antibody that belongs to the pharmacological class called immune checkpoint inhibitors. This medicine is primarily used in combination with other cancer therapies to enhance the body’s immune response against cancer cells. It is classified under the therapeutic category of anti-cancer drugs and is commonly prescribed for conditions like liver cancer and mesothelioma. While Imjudo 300mg Injection 15ml has shown promising results in clinical settings, it must be used with caution. It is not recommended for individuals with severe autoimmune diseases or a history of organ transplant, as it may overstimulate the immune system. Imjudo 300mg Injection 15ml should always be administered under the supervision of an oncology specialist. Patients must be regularly monitored during treatment due to potential risks including immune-related reactions affecting the lungs, liver, or endocrine glands. Pregnant or breastfeeding women should avoid this medication unless clearly advised by their doctor.
Active Pharmaceutical Ingredient
Применение
• Unresectable hepatocellular carcinoma (a type of liver cancer), in combination with durvalumab.
• Malignant pleural mesothelioma (a rare cancer affecting the lining of the lungs), in combination therapies.
Преимущества
This medicine works by helping the body’s immune system recognise and attack cancer cells more effectively. It does this by blocking a protein called CTLA-4 found on certain immune cells. Normally, this protein acts like a brake to prevent the immune system from overreacting. By blocking CTLA-4, Imjudo 300mg Injection 15ml removes this brake, allowing immune cells to stay active longer and fight off cancer cells more powerfully.
Побочные эффекты
Common Side Effects:
Наиболее распространенные побочные эффекты
• Severe diarrhoea or colitis
• Breathing difficulty or chest tightness (signs of pneumonitis)
• Yellowing of the skin or eyes (possible liver issues)
• Hormonal problems like thyroid imbalance
• Eye inflammation or vision problems
Распространенные побочные эффекты
• Tiredness or fatigue
• Diarrhoea or abdominal pain
• Skin rash or itching
• Loss of appetite
• Joint or muscle pain
Как использовать
Imjudo 300mg Injection 15ml is given as an intravenous infusion (IV) by a healthcare professional in a clinical setting. The dosage and schedule are decided based on the patient's weight, type of cancer, and overall health. It is not taken with food or at home. It is often given in combination with other medications like durvalumab, usually once every few weeks. Do not attempt to self-administer or alter the treatment schedule without medical guidance.
Safety Advice
• Breast Feeding: It is unknown whether Imjudo 300mg Injection 15ml passes into breast milk. Women are advised not to breastfeed while receiving this treatment and for some time after.
• Alcohol: There are no direct interactions known, but since Imjudo 300mg Injection 15ml affects the liver, alcohol use should be avoided or discussed with a doctor.
• Liver: Imjudo 300mg Injection 15ml may cause liver inflammation, leading to changes in liver enzymes. Liver function should be regularly monitored.
• Lungs: Imjudo 300mg Injection 15ml can cause inflammation of the lungs (pneumonitis). Patients should report symptoms like shortness of breath or cough immediately.
• Driving: Fatigue and dizziness may occur with Imjudo 300mg Injection 15ml, especially after infusions. Avoid driving if you feel unwell.
• Pregnancy: Imjudo 300mg Injection 15ml may harm an unborn baby and is not recommended during pregnancy. Use effective birth control during treatment and for at least 3 months after the last dose.
Отказ от ответственности
Компания Sidmex Inovia стремится предоставлять точную и достоверную информацию; однако весь контент на этом веб-сайте, включая описания и состав продуктов, предназначен только для информационных целей и не должен рассматриваться как замена профессиональной медицинской консультации, диагностики или лечения.
Пользователям рекомендуется проконсультироваться с квалифицированным медицинским специалистом, прежде чем принимать какие-либо медицинские решения. Предоставленная информация не должна использоваться для самодиагностики или самолечения.
Все перечисленные продукты предназначены исключительно для B2B и оптовых запросов. Sidmex Inovia не пропагандирует прямое использование потребителями и стремится поддерживать, а не заменять отношения между медицинским работником и пациентом.
Названия продуктов, товарные знаки и бренды принадлежат их соответствующим владельцам, и их использование не подразумевает какой-либо связи или одобрения. Sidmex Inovia не несет ответственности за любые последствия, возникающие в результате использования информации, предоставленной на этом веб-сайте.